ORIC Pharmaceuticals, Inc.
ORIC
Analyst Consensus
Price Objectif
Analyst historical
| Analyst | Entreprise | Price during analysis | Target price | Potential gain | Publication date |
|---|---|---|---|---|---|
| Robert Burns | H.C. Wainwright | 13.2661 $ | 25 $ | 11.73 % | 24/02/2026 |
| Matthew Biegler | Oppenheimer | 11.71 $ | 15 $ | 3.29 % | 24/02/2026 |
| Kelsey Goodwin | Piper Sandler | 8.14 $ | 22 $ | 13.86 % | 07/01/2026 |
| Brad Canino | Guggenheim | 10.6 $ | 18 $ | 7.40 % | 04/09/2025 |
| Matthew Biegler | Oppenheimer | 5.04 $ | 12 $ | 6.96 % | 06/05/2025 |
| Bradley Canino | Stifel Nicolaus | 9.48 $ | 20 $ | 10.52 % | 05/09/2024 |
| Robert Burns | H.C. Wainwright | 14.59 $ | 21 $ | 6.41 % | 21/03/2024 |
| David Nierengarten | Wedbush | 14.63 $ | 20 $ | 5.37 % | 12/03/2024 |
| Matthew Biegler | Oppenheimer | 14.32 $ | 17 $ | 2.68 % | 12/03/2024 |
| Yigel Nochomovitz | Citigroup | 6.9 $ | 7 $ | 0.10 % | 05/04/2022 |